Renal dysfunction in patients with spondyloarthritis against the background of various long-term anti-inflammatory therapy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Assessment of renal dysfunction in patients with spondyloarthritis (SpA) who receive various longterm anti-inflammatory therapy during follow-up. Material and methods. The glomerular filtration rate (GFR), α1-microglobulin and urine albumin levels in patients with SpA who received various long-term anti-inflammatory therapy were evaluated initially and after 12 months of follow-up. Results. A decrease in GFR less than 90 ml/min/1.73 m2 was detected in 64 (49.2%) patients with SpA who took non-steroidal anti-inflammatory drugs (NSAIDs) with glucocorticosteroids (GCS), in 37 (52.8%) patients who took only NSAIDs (χ2=0.01, p=0.44). Tubular dysfunction and increased urinary albumin excretion were detected in 86.9% of patients taking NSAIDs alone and in 36.2% of patients taking NSAIDs and GCS (β1 2=4.93; p=0.01). After 12 months of follow-up, in patients with SpA who took NSAIDs and GCS, GFR was higher compared to baseline value: 96 (89-109) and 88 (80-104) ml/min, respectively (p=0.04). In patients who took only NSAIDs, GFR after 12 months of follow-up was 85.5 (77-104) ml/min, with initial GFR 87.5 (75.5-98) ml/min (p>0.05). A decrease in GFR after 12 months of follow-up was more frequently detected in patients who took only NSAIDs than in patients who took NSAIDs and GCS (61.7% and 47.3%, respectively, χ2 with Yates correction=3.4, p=0.03). Conclusion. SpA patients suffered from renal dysfunction of varying severity. At the same time, in patients who received a combination therapy including NSAIDs and GCS, renal dysfunction was less pronounced.

Full Text

Restricted Access

About the authors

A. P Rebrov

Saratov State Medical University n.a. V.l. Razumovsky

Email: andreyrebrov@yandex.ru
Professor, Head of the Department of Hospital Therapy, Faculty of Medicine

E. V. Khondkaryan

Saratov State Medical University n.a. V.I. Razumovsky

Email: ersilasolnce@mail.ru
PhD in Medical Sciences, Teaching Assistant at the Department of Hospital Therapy, Faculty of Medicine

A. V Aparkina

Saratov State Medical University n.a. V.I. Razumovsky

Email: alena437539@yandex.ru
PhD in Medical Sciences, Teaching Assistant at the Department of Hospital Therapy, Faculty of Medicine

I. Z Gaydukova

North-Western State Medical University n.a. I.I. Mechnikov; S

Email: ubp1976@list.ru
PhD in Medical Sciences, Professor at the Department of Therapy, Rheumatology, Examination of Temporary Disability and the Quality of Medical Care n.a. E.E. Eichwald

References

  1. Holm J., Ravn J., Ingemann H.S. Urinary excretion of alphal-microglobulin and albumin in acute myocardial infarction. Correlation with plasma concentrations of troponin I. and Creactive protein. Scand. J. Urol. Nephrol. 2006;40(4):339-344.
  2. Schrader J. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J. Hypertens. 2006;24(3):541-548.
  3. Waheed S. Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study. J. Kidney. Dis. 2012;60(2):207-216.
  4. Rudwaleit M., Landewe R., van der Heijde D., et al. The development of Assessment of Spondyloarthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann. Rheum. Dis. 2009;68(6):770- 776.
  5. Rudwaleit M., van der Heijde D., Landewe R., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (Part II): validation andfinal selection. Ann. Rheum. Dis. 2009;68(6):777-783.
  6. Dougados M., Van der Linden S., Juhlin R., et al. The European Spondylarthropathy Study Group: preliminary criteria for the classification of spondylarthropathy. Arthr. Rheum. 1991;34:1218.
  7. Rudwaleit M., van der Heijde D., Landewe R., et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 2011;70:25-31.
  8. Sieper J. The Assesment of Spondyloarthritis international Society (ASAS) Handbook: a guide to assess spondyloarthritis. Ann. Rheum. Dis. 2009;68(2):1-44. doi: 10.1136/ard.2008.104018.
  9. Garrett S., Jenkinson T., Kennedy L.G., et al. New approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. 1994;21(12):2286-2291.
  10. Levey A.S., Stevens L.A., Coresh J. Conceptual model of CKD: applications and implications. Am. J. Kidney. Dis. 2009;53(3):4-16.
  11. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ Statistica. М.,2002:312.
  12. Alenius G.M., Stegmayr B.G., Dahlqvist S.R. Renal abnormalities in a population of the patients with psoriatic arthritis. Scand. J. Rheum. 2001;30(5):271-274.
  13. Strobel E.S., Fritschka E. Renal Diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin. Rheum. 1998;17(6):524-530.
  14. Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и др. Лечение СпА. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов ( НВПС) в клинической практике». Совр.ревматология.2015;1:4-23.
  15. Эрдес Ш.Ф., Дубинина Т.В., Лапшина С.А. и др. Современные принципы медикаментозной терапии анкилозирующего спондилита. Практическая медицина. 2015;4(2):181-5.
  16. Ravnskov U. Glomerular, tubular and interstitial nephritis associated with nonsteroidal anti-inflammatory drugs. Evidence of a common mechanism. Brit. J. Clin. Pharmacol. 1999;47(2):203-210.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies